{Reference Type}: Journal Article
{Title}: Survey content validation evaluating the dissemination and implementation of deprescribing guidelines.
{Author}: Cheng CHJ;Langford AV;Gnjidic D;Farrell BJ;Schneider CR;
{Journal}: Basic Clin Pharmacol Toxicol
{Volume}: 134
{Issue}: 1
{Year}: 2024 Jan 25
{Factor}: 3.688
{DOI}: 10.1111/bcpt.13922
{Abstract}: <B>BACKGROUND: </B>Policies, protocols and processes within organisations can facilitate or hinder guideline adoption. There is limited knowledge on the strategies used by organisations to disseminate and implement evidence-based deprescribing guidelines or their impact.<BR><B>METHODS: </B>We aimed to develop an online survey targeting key organisations involved in deprescribing guideline endorsement, dissemination, modification or translation internationally. Survey questions were drafted, mirroring the six components of the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) framework. Content validation was undertaken and established by a panel of clinicians, researchers and implementation experts.<BR><B>RESULTS: </B>A 52-item survey underwent two rounds of content validation. The minimum threshold (I-CVI > 0.78) for relevance and importance was met for 39 items (75%) in the first round and 44 of 48 items (92%) in the second round. The expert panel concluded that the adoption, implementation and effectiveness survey sections were largely relevant and important to this topic, whereas the reach and maintenance sections were harder to understand and may be less pertinent to the research question.<BR><B>CONCLUSIONS: </B>A 44-item survey investigating dissemination and implementation strategies for deprescribing guidelines has been developed and its content validated. Widespread survey distribution may identify effective strategies and inform dissemination and implementation planning for newly developed guidelines.